Variability and trait‐specific accessions for grain yield and nutritional traits in germplasm of little millet ( Panicum sumatrense Roth. Ex. Roem. & Schult.)

Little millet (Panicum sumatrense Roth. Ex. Roem. & Schult.), a member of the grass family Poaceae, is native to India. It is nutritionally superior to major cereals, grows well on marginal lands, and can withstand drought and waterlogging conditions. Two-hundred diverse little millet landraces were characterized to assess variability for agronomic and nutritional traits and identify promising accessions. Highly significant variabilitywas found for all the agronomic and grain nutrient traits. Accessions of robusta were high yielding whereas those of nana were rich in grain nutrients. About 80% of the accessions showed consistent protein and zinc (Zn) contents whereas iron (Fe) and calcium (Ca) contents were less consistent (29.5 and 63.5%, respectively) over 2 yr. Promising trait-specific accessions were identified for greater seed weight (10 accessions), high grain yield (15), high biomass yield (15), and consistently high grain nutrients (30) over 2 yr (R2 = .69–.74, P ≤ .0001). A few accessions showed consistently high for two or more nutrients (IPmr 449 for Fe, Zn, Ca, and protein; IPmr 981 for Zn and protein). Five accessions (IPmr 855, 974, 877, 897, 767) were high yielding and also rich in Ca. Consumption of 100 g of little millet grains can potentially contribute to the recommended dietary allowance of up to 28% Fe, 37% Zn, and 27% protein. Multilocation evaluation of the promising accessions across different soil types, fertility levels, and climatic conditions would help to identify valuable accessions for direct release as a cultivar or use in little millet improvement

Stem Cell-Based and Tissue Engineering Approaches for Skeletal Muscle Repair

Skeletal muscle tissue exhibits significant regeneration capacity upon injury or disease. This intrinsic regeneration potential is orchestrated by stem cells termed satellite cells, which undergo activation and differentiation in response to muscle insult, giving rise to fusion-competent myogenic progenitors responsible for tissue rejuvenation. Skeletal muscle diseases such as Duchenne muscular dystro-phy are characterized by progressive loss of muscle mass which precipitates reduced motility, paralysis, and in some occurrences untimely death. A manifold of muscle pathologies involve a failure to efficiently regenerate the muscle tissue, rendering stem cell-based approaches an attractive therapeutic strategy. Here we will present past and contemporary methods to treat skeletal muscle degeneration by stem cell therapy, covering prominent challenges facing this technology and potential means to overcome current hurdles. A primary focus of this chapter is directed toward illustrating innovative ways to utilize stem cells alone or in conjunction with biomaterials and tissue engineering techniques to remedy Duchenne muscular dystrophy or volumetric muscle loss